Concepedia

Publication | Open Access

Humanized Anti-Interleukin-6 Receptor Antibody Suppresses Tumor Angiogenesis and <i>In vivo</i> Growth of Human Oral Squamous Cell Carcinoma

161

Citations

38

References

2009

Year

Abstract

Therapeutic approaches targeting IL-6R by tocilizumab may be effective for OSCC treatment by at least inhibiting angiogenesis.

References

YearCitations

Page 1